Morneau Seeks Drug Plan That Won’t ‘Throw Out’ Current System
(Bloomberg) -- Canadian finance minister Bill Morneau is signaling he won't introduce a big-ticket universal plan to cover drug costs, opting instead for a cheaper solution that helps the uninsured.
In his budget on Tuesday, Morneau announced the creation of an Advisory Council on the Implementation of National Pharmacare. On Wednesday, he drew a distinction between a “pharmacare strategy” and a “pharmacare plan,” saying he wants the former and doesn't want to totally upend the current system that includes companies like Manulife Financial Corp. and Great-West Lifeco Inc., which is controlled by Power Corp. of Canada.
A strategy and a plan “are two very different things,” Morneau told a breakfast audience in Ottawa. “We recognize that we need a strategy to deal with the fact that not everyone has access, and we need to do it in a way that's responsible, that deals with the gaps, that doesn't throw out the system that we currently have.”
The net cost for the federal government to pay for pharmaceutical coverage would be C$19.3 billion ($15.1 billion), and doing so would include drugs that currently cost about C$24.6 billion, according to Canada's parliamentary budget officer, an independent watchdog. About C$11.9 billion of that is covered by a mix of governments, while private insurance plans cover C$9 billion and patients paying out-of-pocket account for C$3.6 billion, the PBO estimated.
Morneau's comments suggest it's the patients' share he wants to address. About one million Canadians don't have access to pharmaceuticals, he said. “We recognize that we have a real gap right now,” he said, adding those who can't get the drugs they need “are in a tough situation where they're making choices.”
These are the key takeaways from Canada's 2018-19 federal budget
Asked by reporters afterward about the comments, he said they were his “perspective” and that the advisory council's work will be led by former Ontario Health Minister Eric Hoskins. “There are parts of the system that are working well, there are parts of the system that really aren't working well. We need to consider both those parts,” he said.
Morneau called the issue complicated and has repeatedly said he needs to be “fiscally responsible” in how he proceeds.
Pharmacare is a core pledge of the left-leaning New Democratic Party, which often jockeys for votes with Trudeau's Liberals in Canada's largely three-party system. The NDP is pushing for full universal pharmacare. “The millions of Canadians who can't afford their prescription drugs don't need another study; they need their leaders to find the courage to act immediately,” NDP finance critic Peter Julian said in a written statement Tuesday.
To contact the reporter on this story: Josh Wingrove in Ottawa at jwingrove4@bloomberg.net.
To contact the editors responsible for this story: Theophilos Argitis at targitis@bloomberg.net, Chris Fournier, Stephen Wicary
©2018 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.